Results 1 to 10 of about 4,369 (260)
Transient Sensorineural Hearing Loss and Rhabdomyolysis, Associated With Chronic Kratom Use. [PDF]
Kratom is a colloquial name for products derived from the mitragyna plant species originating in Southeast Asia and now widely available in the United States as a dietary supplement. Kratom is used primarily for self‐management of pain, anxiety, and opioid withdrawal due to its partial agonist activity on mu opioid receptors, as well as other ...
Watanabe H, Zhang K, Shapiro Y.
europepmc +2 more sources
Commentary on Comstock et al.: Here we go again-Kratom and the failure to learn from the opioid crisis. [PDF]
Addiction, Volume 121, Issue 9, Page 2468-2469, September 2026.
Kolodny A.
europepmc +2 more sources
Background Kratom alleviates pain by activating μu-opioid receptors (MOR), which trigger serotonin release to produce analgesia. Serotonin also interferes drug abuse effect.
Dwi Wahyu Indriani +7 more
doaj +2 more sources
Although kratom use has been part of life for centuries in Southeast Asia, the availability and use of kratom in the United States (US) increased substantially since the early 2000s when there was little information on kratom pharmacology, use patterns ...
Jack E. Henningfield +4 more
doaj +2 more sources
Assessment of Abuse Potential-Related Effects of Oral Dried Kratom Leaf Powder in Healthy Normal Participants Following Single and Multiple Daily Doses. [PDF]
In a randomized, double‐blind, placebo‐controlled study of oral dried kratom leaf powder in healthy kratom‐naive adults, no participants met the clinically meaningful opioid withdrawal threshold; abuse‐related treatment‐emergent adverse events occurred more frequently at higher doses but were generally mild and resolved without sequelae; and no serious
Coe M +5 more
europepmc +2 more sources
Introduction: Kratom use is increasing in the US, yet data characterizing use patterns, risks, and benefits is limited. Additionally, there are few data on the acute subjective effects of kratom in humans, and no studies to-date have examined kratom use ...
Cianna J. Piercey +10 more
doaj +2 more sources
Kratom is derived from Mitragyna speciosa and contains active alkaloids that bind opioid, alpha-2 adrenergic, and 5-HT2A receptors. In vitro studies show kratom can inhibit myocardial potassium channels. We present a patient who developed a reversible Brugada pattern and QT prolongation after self-treating his attention-deficit/hyperactivity disorder ...
Andrew H.F. Miller +6 more
openaire +3 more sources
Characteristics of adverse reactions to kratom and implementation of harm reduction strategies in a sample of ethnobotanical tea bar patrons in Colorado [PDF]
Background Kratom is a psychoactive botanical that is increasingly popular in the United States. While potential risks of kratom use have been identified, research on harm reduction strategies and contextual factors contributing to adverse reactions is ...
Cianna J. Piercey +9 more
doaj +2 more sources
Kratom (Mitragyna speciosa (Korth.) Havil.) has been reported to reduce serum lipids. However, the molecular mechanism underlying hypolipidaemic effect of kratom is still unclear.
Nantiya Nawaka +4 more
doaj +2 more sources
Reported associations between kratom and seizures: a systematic review
Statement of purpose, innovation or hypothesisKratom, derived from the leaves of the plant Mitragyna speciosa, is an herbal supplement that has been used medically and recreationally for centuries, but has recently gained popularity in the United States ...
Toby Turla +3 more
doaj +2 more sources

